Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gene therapy and apheresis

P Servida1, C Bordignon

  • 1Service of Hematology, IRCCS San Raffaele Hospital, Milano, Italy.

The International Journal of Artificial Organs
|December 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Early recovery of CMV immunity after HLA-haploidentical hematopoietic stem cell transplantation as a surrogate biomarker for a reduced risk of severe infections overall.

Bone marrow transplantation·2015
Same author

Haploidentical HSCT: a 15-year experience at San Raffaele.

Bone marrow transplantation·2015
Same author

Incidence, risk factors and clinical outcome of leukemia relapses with loss of the mismatched HLA after partially incompatible hematopoietic stem cell transplantation.

Leukemia·2014
Same author

Sirolimus-based graft-versus-host disease prophylaxis promotes the in vivo expansion of regulatory T cells and permits peripheral blood stem cell transplantation from haploidentical donors.

Leukemia·2014
Same author

NGR-TNF, a novel vascular-targeting agent, does not induce cytokine recruitment of proangiogenic bone marrow-derived cells.

British journal of cancer·2013
Same author

Phase I and pharmacodynamic study of high-dose NGR-hTNF in patients with refractory solid tumours.

British journal of cancer·2012

Gene therapy offers a promising treatment for genetic disorders affecting blood cell development (hematopoiesis). Apheresis enables efficient collection and manipulation of hematopoietic stem cells for therapeutic gene transfer.

Area of Science:

  • Hematology
  • Gene Therapy
  • Molecular Biology

Background:

  • Gene therapy is emerging as a viable treatment for certain genetic disorders.
  • Hematopoietic stem cells are primary targets due to ease of collection and manipulation.
  • Apheresis techniques efficiently collect large numbers of peripheral blood mononuclear cells for transfection.

Purpose of the Study:

  • To explore the potential of gene therapy for hematopoietic genetic disorders.
  • To highlight the role of apheresis in cell collection for gene therapy.
  • To discuss future applications of gene therapy in hematology.

Main Methods:

  • Utilizing apheresis for mononuclear cell collection.
  • Employing gene transfection techniques on hematopoietic progenitors.

Related Experiment Videos

  • Investigating hematopoietic stem cell manipulation.

    • Main Results:

    • Demonstrated feasibility of collecting sufficient hematopoietic progenitors via apheresis.
    • Established potential for gene manipulation in these cells.
    • Identified gene therapy as a promising avenue for treating blood disorders.

    Conclusions:

    • Gene therapy holds significant therapeutic potential for genetic hematopoietic disorders.
    • Apheresis is a key enabling technology for efficient cell collection in gene therapy.
    • Future applications include gene marking and enhancing drug resistance in hematopoietic cells.